首页> 美国卫生研究院文献>Stem Cells International >Mesenchymal Stem Cell Therapy Facilitates Donor Lung Preservation by Reducing Oxidative Damage during Ischemia
【2h】

Mesenchymal Stem Cell Therapy Facilitates Donor Lung Preservation by Reducing Oxidative Damage during Ischemia

机译:间充质干细胞疗法通过减少缺血期间的氧化损伤促进供体肺保存

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Lung transplantation is a lifesaving therapy for people living with severe, life-threatening lung disease. The high mortality rate among patients awaiting transplantation is mainly due to the low percentage of lungs that are deemed acceptable for implantation. Thus, the current shortage of lung donors may be significantly reduced by implementing different therapeutic strategies which facilitate both organ preservation and recovery. Here, we studied whether the anti-inflammatory effect of human umbilical cord-derived mesenchymal stem cells (HUCPVCs) increases lung availability by improving organ preservation. We developed a lung preservation rat model that mimics the different stages by which donor organs must undergo before implantation. The therapeutic schema was as follows: cardiac arrest, warm ischemia (2 h at room temperature), cold ischemia (1.5 h at 4°C, with Perfadex), and normothermic lung perfusion with ventilation (Steen solution, 1 h). After 1 h of warm ischemia, HUCPVCs (1 × 106 cells) or vehicle was infused via the pulmonary artery. Physiologic data (pressure-volume curves) were acquired right after the cardiac arrest and at the end of the perfusion. Interestingly, although lung edema did not change among groups, lung compliance dropped to 34% in the HUCPVC-treated group, while the vehicle group showed a stronger reduction (69%, p < 0.0001). Histologic assessment demonstrated less overall inflammation in the HUCPVC-treated lungs. In addition, MPO activity, a neutrophil marker, was reduced by 41% compared with vehicle (p < 0.01). MSC therapy significantly decreased tissue oxidative damage by controlling reactive oxygen species production. Accordingly, catalase and superoxide dismutase enzyme activities remained at baseline levels. In conclusion, these results demonstrate that the anti-inflammatory effect of MSCs protects donor lungs against ischemic injury and postulates MSC therapy as a novel tool for organ preservation.
机译:对于患有严重威胁生命的肺部疾病的人,肺移植是一种挽救生命的疗法。等待移植的患者中较高的死亡率主要是由于被认为可以接受的肺部百分比低。因此,通过实施促进器官保存和恢复的不同治疗策略,可以显着减少目前肺供体的短缺。在这里,我们研究了人脐带间充质干细胞(HUCPVCs)的抗炎作用是否通过改善器官保存来增加肺部的利用率。我们开发了一个肺保存大鼠模型,该模型模仿了供体器官植入前必须经历的不同阶段。治疗方案如下:心脏骤停,温暖的局部缺血(在室温下2 coldh),寒冷的局部缺血(在4°C下使用Perfadex在1.5°h下)和通气的常温肺灌注(Steen溶液,1?h)。在热缺血1 h后,通过肺动脉注入HUCPVC(1×10 6 细胞)或媒介物。在心脏骤停后和灌注结束时获取生理数据(压力-容量曲线)。有趣的是,尽管各组之间的肺水肿没有改变,但HUCPVC治疗组的肺顺应性下降至34%,而赋形剂组表现出更强的减少(69%,p <0.0001)。组织学评估显示,HUCPVC处理的肺部总体炎症较少。此外,与媒介物相比,嗜中性粒细胞标志物MPO活性降低了41%(p <0.01)。 MSC治疗通过控制活性氧的产生显着降低了组织的氧化损伤。因此,过氧化氢酶和超氧化物歧化酶的活性保持在基线水平。总之,这些结果表明,MSC的抗炎作用可保护供体肺免受缺血性损伤,并假定MSC治疗是器官保存的新工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号